Pulmonx Corporation (LUNG)
NASDAQ: LUNG · IEX Real-Time Price · USD
7.52
+0.02 (0.27%)
At close: Apr 24, 2024, 4:00 PM
7.66
+0.14 (1.86%)
After-hours: Apr 24, 2024, 4:14 PM EDT
Pulmonx Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Pulmonx stock have an average target of 15.57, with a low estimate of 12 and a high estimate of 18. The average target predicts an increase of 107.05% from the current stock price of 7.52.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Pulmonx stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $17 | Buy | Reiterates | $17 | +126.06% | Apr 3, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $16 → $17 | Strong Buy | Maintains | $16 → $17 | +126.06% | Feb 23, 2024 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $16 → $14 | Buy → Hold | Downgrades | $16 → $14 | +86.17% | Feb 23, 2024 |
| Stifel | Stifel | Strong Buy Maintains $15 → $17 | Strong Buy | Maintains | $15 → $17 | +126.06% | Feb 22, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $13 → $17 | Buy | Maintains | $13 → $17 | +126.06% | Feb 22, 2024 |
Financial Forecast
Revenue This Year
83.83M
from 68.68M
Increased by 22.07%
Revenue Next Year
99.40M
from 83.83M
Increased by 18.57%
EPS This Year
-1.89
from -1.60
EPS Next Year
-1.58
from -1.89
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 87.0M | 106.2M | 129.9M | 154.0M |
| Avg | 83.8M | 99.4M | 119.5M | 149.6M |
| Low | 79.5M | 90.9M | 110.5M | 143.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 26.7% | 26.6% | 30.7% | 28.9% |
| Avg | 22.1% | 18.6% | 20.2% | 25.2% |
| Low | 15.7% | 8.5% | 11.1% | 20.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -1.87 | -1.23 | -0.66 | -0.81 |
| Avg | -1.89 | -1.58 | -1.29 | -0.79 |
| Low | -1.90 | -1.77 | -1.74 | -0.75 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | - |
| Avg | - | - | - | - |
| Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.